First-in-Human Experience With the EnCompass F2 Filter, a Novel Cerebral Embolic Protection Device for TAVR
In this first-in-human series, cerebral embolic protection with the EnCompass F<sub>2</sub> during TAVR was feasible and safe with very low new brain DW-MRI lesion volumes and no strokes.
Authors
- Irakli Gogorishvili (ORCID: https://orcid.org/0000-0001-7645-7494)
- Tamim Nazif (ORCID: https://orcid.org/0000-0003-1239-2489)
- Gvantsa Dughashvili
- David Blusztein (ORCID: https://orcid.org/0000-0003-0907-5968)
- May Nour (ORCID: https://orcid.org/0000-0001-5493-9679)
- Isaac George (ORCID: https://orcid.org/0000-0001-7770-4450)
- Viktor Szeder
- Keith Woodward
Institutions
- Valve (United States) (US)
- Columbia University Irving Medical Center (US)
- eHealth Africa (US)
- Monash Health (AU)
- Imaging Technology Consulting (United States) (US)
- Tbilisi State Medical University (GE)
Publication Details
- Journal
- Journal of the Society for Cardiovascular Angiography & Interventions
- Published
- 2025-08-12
- DOI
- https://doi.org/10.1016/j.jscai.2025.103608
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00